Drug
Sertindole
Sertindole: highest development phase Post-Market, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sertindole NCT00763438 | Post-Market | Schizophrenia |
Latest
No recent events.
Follow Sertindole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.